Cargando…

The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy

BACKGROUND: Cervical lymph node metastasis was an important prognostic factor. However, the prognosis of the maximum diameter of cervical lymph nodes before treatment has always been controversial. The aim of this study was to analyze the relationship between treatment outcomes and the maximum diame...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Weiqiong, Gao, Yunsheng, Xu, Fei, Cao, Weiguo, Xu, Cheng, Chen, Jiayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798367/
https://www.ncbi.nlm.nih.gov/pubmed/35116818
http://dx.doi.org/10.21037/tcr.2019.04.22
_version_ 1784641788013707264
author Ni, Weiqiong
Gao, Yunsheng
Xu, Fei
Cao, Weiguo
Xu, Cheng
Chen, Jiayi
author_facet Ni, Weiqiong
Gao, Yunsheng
Xu, Fei
Cao, Weiguo
Xu, Cheng
Chen, Jiayi
author_sort Ni, Weiqiong
collection PubMed
description BACKGROUND: Cervical lymph node metastasis was an important prognostic factor. However, the prognosis of the maximum diameter of cervical lymph nodes before treatment has always been controversial. The aim of this study was to analyze the relationship between treatment outcomes and the maximum diameter of lymph nodes (Dmax) in loco-regional advanced nasopharyngeal carcinoma (NPC) after intensity modified radiotherapy. METHODS: From Jan. 2012 to Dec. 2017, 163 patients with locally advanced NPC treated with intensity modified radiotherapy were retrospectively analyzed. The T-stage distribution was 6.7% in T1, 23.3% in T2, 38.7% in T3, and 31.3% in T4. The N-classifications were 6.1% in N0, 23.3% in N1, 47.9% in N2, and 22.7% in N3. TNM stages were III 51.5% and IVa 48.5%. All patients received intensity modified radiotherapy to the nasopharynx and neck. The dose was 66–70.4 Gy, 2–2.2 Gy per fraction over 6–7 weeks to the primary tumor and lymph nodes and 54–60 Gy to clinical target volumes (CTVs). One hundred fifty patients were received induction chemotherapy and/or concurrent chemotherapy. The maximum diameter of the lymph node is measured on the axial or coronal MRI image. RESULTS: The median follow-up time was 31 months (range, 6.1–79.3 months). Six cases developed neck recurrence and 9 cases developed nasopharynx recurrence. The lymph nodes diameter was 0–12 cm, median 2.9 cm. Three-year overall survival (OS) rate was 77.8%. Three-year local failure-free rate (L-FFR), distant failure-free rate (D-FFR) and disease-free survival (DFS) rate were 88.1%, 77.6% and 63.9% respectively. Multivariate analysis showed Dmax was not a prognostic factor for OS, L-FFR, D-FFR, DFS. Both uni- and multivariate analyses demonstrated that N-classification and age is the significant prognostic factor for predicting OS while the maximum diameter of lymph nodes, T-classification, N-classification and AJCC-classification are the significant prognostic factor for predicting OS in univariate analyses in local-regional advanced NPC. CONCLUSIONS: The maximum diameter of the lymph nodes was not a prognostic factor for local-regional advanced NPC treated with intensity modulated radiotherapy.
format Online
Article
Text
id pubmed-8798367
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87983672022-02-02 The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy Ni, Weiqiong Gao, Yunsheng Xu, Fei Cao, Weiguo Xu, Cheng Chen, Jiayi Transl Cancer Res Original Article BACKGROUND: Cervical lymph node metastasis was an important prognostic factor. However, the prognosis of the maximum diameter of cervical lymph nodes before treatment has always been controversial. The aim of this study was to analyze the relationship between treatment outcomes and the maximum diameter of lymph nodes (Dmax) in loco-regional advanced nasopharyngeal carcinoma (NPC) after intensity modified radiotherapy. METHODS: From Jan. 2012 to Dec. 2017, 163 patients with locally advanced NPC treated with intensity modified radiotherapy were retrospectively analyzed. The T-stage distribution was 6.7% in T1, 23.3% in T2, 38.7% in T3, and 31.3% in T4. The N-classifications were 6.1% in N0, 23.3% in N1, 47.9% in N2, and 22.7% in N3. TNM stages were III 51.5% and IVa 48.5%. All patients received intensity modified radiotherapy to the nasopharynx and neck. The dose was 66–70.4 Gy, 2–2.2 Gy per fraction over 6–7 weeks to the primary tumor and lymph nodes and 54–60 Gy to clinical target volumes (CTVs). One hundred fifty patients were received induction chemotherapy and/or concurrent chemotherapy. The maximum diameter of the lymph node is measured on the axial or coronal MRI image. RESULTS: The median follow-up time was 31 months (range, 6.1–79.3 months). Six cases developed neck recurrence and 9 cases developed nasopharynx recurrence. The lymph nodes diameter was 0–12 cm, median 2.9 cm. Three-year overall survival (OS) rate was 77.8%. Three-year local failure-free rate (L-FFR), distant failure-free rate (D-FFR) and disease-free survival (DFS) rate were 88.1%, 77.6% and 63.9% respectively. Multivariate analysis showed Dmax was not a prognostic factor for OS, L-FFR, D-FFR, DFS. Both uni- and multivariate analyses demonstrated that N-classification and age is the significant prognostic factor for predicting OS while the maximum diameter of lymph nodes, T-classification, N-classification and AJCC-classification are the significant prognostic factor for predicting OS in univariate analyses in local-regional advanced NPC. CONCLUSIONS: The maximum diameter of the lymph nodes was not a prognostic factor for local-regional advanced NPC treated with intensity modulated radiotherapy. AME Publishing Company 2019-06 /pmc/articles/PMC8798367/ /pubmed/35116818 http://dx.doi.org/10.21037/tcr.2019.04.22 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Ni, Weiqiong
Gao, Yunsheng
Xu, Fei
Cao, Weiguo
Xu, Cheng
Chen, Jiayi
The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
title The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
title_full The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
title_fullStr The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
title_full_unstemmed The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
title_short The maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
title_sort maximum diameter of cervical lymph node was not a prognostic factor for local-regional advanced nasopharyngeal carcinoma treated with intensity modified radiotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798367/
https://www.ncbi.nlm.nih.gov/pubmed/35116818
http://dx.doi.org/10.21037/tcr.2019.04.22
work_keys_str_mv AT niweiqiong themaximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT gaoyunsheng themaximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT xufei themaximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT caoweiguo themaximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT xucheng themaximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT chenjiayi themaximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT niweiqiong maximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT gaoyunsheng maximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT xufei maximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT caoweiguo maximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT xucheng maximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy
AT chenjiayi maximumdiameterofcervicallymphnodewasnotaprognosticfactorforlocalregionaladvancednasopharyngealcarcinomatreatedwithintensitymodifiedradiotherapy